Prestimulus modification of the startle reflex: Relationship to personality and physiological markers of dopamine function

Biological Psychology

Volumn 62, Issue 1, 2003, Pages 17-26

  Swerdlow, Neal R ^a   Wasserman, Lindsay C ^a   Talledo, Jo Anne ^a   Casas, Rachel ^a   Bruins, Pieter ^a   Stephany, Nora L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blink; Dopamine; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Startle reflex; TPQ

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINE BRAIN LEVEL; ELECTROMYOGRAM; EYELID REFLEX; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARKINSON DISEASE; PERSONALITY; PHYSIOLOGY; PREPULSE INHIBITION; PRIMATE; PRIORITY JOURNAL; QUESTIONNAIRE; RODENT; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ADOLESCENT; ADULT; BLINKING; DOPAMINE; ELECTROMYOGRAPHY; HUMANS; MALE; PERCEPTION; PERSONALITY; STARTLE REACTION;

EID: 0037276681     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0511(02)00090-X     Document Type: Article

References (53)

1. Abduljawad K.A., Langley R.W., Bradshaw C.M., Szabadi E. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. Journal of Psychopharmacology. 12:1998;239-245.
2. Benjamin J., Osher Y., Kotler M., Gritsenko I., Nemanov L., Belmaker R.H., et al. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Molecular Psychiatry. 5:2000;96-100.
3. Blin O., Masson G., Azulay J.P., Fondarai J., Serratrice G. Apomorphine-induced blinking and yawning in healthy volunteers. British Journal of Clinical Pharmacology. 30:1990;769-773.
4. Blumenthal T.D., Schicatano E.J., Chapman J.G., Norris C.M., Ergenzinger E.R. Jr. Prepulse effects on magnitude estimation of startle-eliciting stimuli and startle responses. Perception and Psychophysics. 58:1996;73-80.
5. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
6. Caplan R., Guthrie D. Blink rate in childhood schizophrenia spectrum disorder. Biological Psychiatry. 35:1994;228-234.
7. Castellanos F.X., Fine E.J., Kaysen D.L., Kozuch P.L., Hamburger S.D., Rapoport J.L., et al. Sensorimotor gating in boys with Tourette's Syndrome and ADHD: preliminary results. Biological Psychiatry. 39:1996;33-41.
8. Cloninger C.R., Przybeck T.R., Svrakic D.M. The tridimensional personality questionnaire: US normative data. Psychological Reports. 69:1991;1047-1057.
9. Ebstein R.P., Nemanov L., Klotz I., Gritsenko I., Belmaker R.H. Additional evidence for an association between the dopamine D4 receptor in III repeat polymorphism and the human personality trait of Novelty Seeking. Molecular Psychiatry. 2:1997;472-477.
10. Elsworth J.D., Lawrence M.S., Roth R.H., Taylor J.R., Mailman R.B., Nichols D.E., et al. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. Journal of Pharmacology and Experimental Therapeutics. 259:1991;595-600.
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IVAxis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). 1997;Biometrics Research, New York State Psychiatric Institute, New York.
12. Gomez-Wong E., Marti M.J., Tolosa E., Valls-Sole J. Sensory modulation of the blink reflex in patients with blepharospasm. Archives of Neurology. 55:1998;1233-1237.
13. Graham F. The more or less startling effects of weak prestimuli. Psychophysiology. 12:1975;238-248.
14. Hallett M. Clinical physiology of dopa dyskinesia. Annals of Neurology. 47:(4 Suppl. 1):2000;S147-S150.
15. Hantraye P., Varaset M., Peschanski M., Riche D., Cesaro P., Willer J.C., et al. Stable parkinsonism syndrome and uneven loss of striatal dopamine fibers following chronic MPTP administration in baboons. Neuroscience. 53:1993;169-178.
16. Hutchison K.E., Swift R. Effect of D-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology. 143:1999;394-400.
17. Hutchison K.E., Wood M.D., Swift R. Personality factors moderate subjective and psychophysiological responses to D-amphetamine in humans. Experimental Clinical Psychopharmacology. 7:1999;493-501.
18. Jacobs H., Heberlein I., Vieregge A., Vieregge P. Personality traits in young patients with Parkinson's disease. Acta Neurologica Scandinavica. 103:2001;82-87.
19. Jacobsen L.K., Hommer D.W., Hong W.L., Castellanos F.X., Frazier J.A., Giedd J.N., et al. Blink rate in childhood-onset schizophrenia: comparison with normal and attention-deficit hyperactivity disorder controls. Biological Psychiatry. 40:1996;1222-1229.
20. Jouvet, M., 1975. Biochemical regulation of states of vigilance. International Journal of Neurosciences 10, 141-157, 252-258.
21. Karson C.N. Physiology of normal and abnormal blinking. Advanced Neurology. 49:1988;25-37.
22. Karson C.N., Staub R.A., Kleinman J.E., Wyatt R.J. Drug effect on blink rates in rhesus monkeys: preliminary studies. Biological Psychiatry. 16:1980;249-255.
23. Karson C.N., LeWitt P.A., Calne D.B., Wyatt R.J. Blink rates in parkinsonism. Annals of Neurology. 12:1982;580-583.
24. Karson C.N., Burns R.S., LeWitt P.A., Foster N.L., Newman R.P. Blink rates and disorders of movement. Neurology. 34:1984;677-678.
25. Karson C.N., Dykman R.A., Paige S.R. Blink rates in schizophrenia. Schizophrenia Bulletin. 16:1990;345-354.
26. Katsuragi S., Kiyota A., Tsutsumi T., Isogawa K., Nagayama H., Arinami T., et al. Lack of association between a polymorphism in the promoter region of the dopamine D2 receptor and personality traits. Psychiatry Research. 105:2001;123-127.
27. Kleven M.S., Koek W. Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys. Journal of Pharmacology and Experimental Therapeutics. 279:1996;1211-1219.
28. Koch M., Bubser M. Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. European Journal of Neuroscience. 6:1994;1837-1845.
29. Koch M., Schnitzler H.-U. The acoustic startle response in rats - circuits mediating evocation, inhibition and potentiation. Behavior Brain Research. 89:1997;35-49.
30. Kuhn K.U., Meyer K., Nothen M.M., Gansicke M., Papassotirepoulos A., Maier W. Allelic variants of dopamine receptor D4 (DRD4) and seratonin receptor 5HT2c (HTR2c) and temperament factors: replication tests. American Journal of Medical Genetics. 88:1999;168-172.
31. Lawrence M.S., Redmond D.E. Jr. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacology Biochemistry and Behavior. 38:1991;869-874.
32. Lawrence M.S., Redmond D.E. Jr, Elsworth J.D., Taylor J.R., Roth R.H. The D1 receptor antagonist, SCH23390, induces signs of parkinsonism in African green monkeys. Life Sciences Pharmacology Letters. 49:1991;PL229-PL234.
33. Mackert A., Woyth C., Flechtner K.M., Volz H.P. Increased blink rate in drug-naive acute schizophrenic patients. Biological Psychiatry. 27:1990;1197-1202.
34. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
35. Menza M.A., Forman N.E., Goldstein H.S., Golbe L.I. Parkinson's disease, personality, and dopamine. Journal of Neuropsychiatry and Clinical Neurosciences. 2:1990;282-287.
36. Noble E.P., Ozkaragoz T.Z., Ritchie T.L., Zhang X., Belin T.R., Sparkes R.S. D2 and D4 dopamine receptor polymorphisms and personality. American Journal of Medical Genetics. 81:1998;257-267.
37. Stevens J.R. Disturbances of ocular movements and blinking in schizophrenia. Journal of Neurology, Neurosurgery and Psychiatry. 41:1978;1024-1030.
38. Stevens J.R. Eye blink rate and schizophrenia: psychosis or tardive dyskinesia. American Journal of Psychiatry. 135:(2):1978;224-226.
39. Strobel A., Wehr A., Michel A., Brocke B. Association between dopamine D4 receptor (DRD4) exon III polymorphism and measures of Novelty Seeking in a German population. Molecular Psychiatry. 4:1999;378-384.
40. Swarztrauber K., Fujikawa D.G. An electroencephalographic study comparing maximum blink rates in schizophrenic and nonschizophrenic psychiatric patients and nonpsychiatric control subjects. Biological Psychiatry. 43:1998;282-287.
41. Swerdlow N.R. Cortico-striatal substrates of cognitive, motor and sensory gating: speculations and implications for psychological function and dysfunction. Panksepp J. Advances in Biological Psychiatry. 2:1996;179-208 JAI Press, Greenwich, CT.
42. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin. 24:1998;285-302.
43. Swerdlow N.R., Geyer M., Braff D., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle in schizophrenics. Biological Psychiatry. 21:1986;23-33.
44. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in Schizophrenic patients. Archives of General Psychiatry. 51:1994;139-154.
45. Swerdlow N.R., Filion D., Geyer M.A., Braff D.L. 'Normal' personality correlates of sensorimotor, cognitive and visuo-spatial gating. Biological Psychiatry. 37:1995;286-299.
46. Swerdlow N.R., Geyer M.A., Perry W., Cadenhead K., Braff D.L. Drug screening in 'normal' controls. Biological Psychiatry. 38:1995;123-124.
47. Swerdlow N.R., Hartman P.L., Auerbach P.P. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biological Psychiatry. 41:1997;452-460.
48. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuitry of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology. 156:2001;194-215.
49. Swerdlow, N.R., Stephany, N., Shoemaker, J.M., Ross, L., Wasserman, L.C., Talledo, J., Auerbach, P.P., 2002a. Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology, in press.
50. Swerdlow, N.R., Stephany, N., Wasserman, L.C., Talledo, J., Shoemaker, J.M., Auerbach, P.P., 2002b. Amphetamine effects on prepulse inhibition across species: replication and parametric extension. Neuropsychopharmacology, in press.
51. Taylor J.R., Lawrence M.S., Redmond D.E. Jr, Elsworth J.D., Roth R.H., Nichols D.E., et al. Dihydrexidine, a full D1 agonist, reduces MPTP-induced parkinsonism in African green monkeys. European Journal of Pharmacology. 199:(III):1991;387-388.
52. Taylor J.R., Elsworth J.D., Lawrence M.S., Sladek J.R. Jr, Roth R.H., Redmond D.E. Jr. Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Experimental Neurology. 158:1999;214-220.
53. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of mesocortical DA system by stress. Nature. 263:1976;242-244.